One of the many harmful factors faced by the skin is solar UV radiation, which damages skin by inducing chronic low grade inflammation through increased expression of proinflammatory cytokines, metalloproteinases (MMPs) and cycloxygenase-2 (COX-2).
MOL #62877

INTRODUCTION
Photoaging results from the repetitive exposure of skin to damaging effects of solar UV radiation, and is characterized by wrinkles, laxity, dryness and mottled pigmentation. In recent years, some of the molecular mechanisms underlying the etiology of photoaging have been described. The process of photoaging involves three cell types, namely keratinoytes, fibroblasts, and infiltrating neutrophils (Makrantonaki and Zouboulis, 2007; Fisher et al., 2002; Rijken et al., 2005) . Within minutes of UVB radiation exposure, epidermal keratinocytes show an increased activation of transcription factors, activator protein 1 (AP-1) and nuclear factor-kB (NF-kB), resulting in high expression of matrix metalloproteinases (MMPs) and pro-inflammatory cytokines (Fisher et al., 1996) . These cytokines as well as UVA component of the UV radiation in turn activate dermal fibroblasts to secrete MMPs, which damage the collagen component of the dermal extracellular matrix (Fagot et al., 2004) . Cytokines and chemotactic factors that are secreted by skin cells also recruit neutrophilic granulocytes to the dermis. These neutrophils further degrade dermal extracellular matrix by secreting MMPs and elastases, thus contributing to UV-mediated dermal collagen and elastin degradation (Rijken et al., 2005) . Repetitive UV exposure leads to the accumulation of partially degraded extracellular matrix components in the dermis, resulting in wrinkle appearance.
Therefore, a number of pathways and processes involved in photoaging could be targeted by potential therapeutic agents. , 2003) . Both ERα and β are expressed in human epidermal keratinocytes and dermal fibroblasts and their natural ligand, estrogen, has profound influence on skin (Haczynski et al., 2004; Walker and Korach, 2004) . Importantly, estrogen has been shown to decrease aging and wrinkling of the skin when used therapeutically (Wolff et al., 2005) .
Estrogen prevents aging by increasing skin thickness, dermal collagen content and water holding capacity of post-menopausal skin. Estrogen increased skin moisture by strengthening epidermal barrier and enhancing the production of hydrophilic glycosaminoglycans in the dermis (Quatresooz and Pierard, 2007) . Since ERα agonism is associated with unwanted breast and uterine side effects (Jordan, 2002) , we decided to examine the possibility of using ERβ as a therapeutic target for prevention and treatment of photoaging. Our notion that ERβ ligands could be used for photoaging was also strengthened by the in vivo efficacy observed with an ERβ compound in pre-clinical models of rheumatoid arthritis, inflammatory bowel disease, and inflammatory/chemical induced pain (Leventhal et al., 2006) . ER ligands have been proposed to mediate their anti-inflammatory effects by inhibiting NF-kB-dependent gene expression via involvement of cofactor SRC-2 (Cvoro et al., 2006; Cvoro et al., 2008) . In addition, topical estradiol has been shown to increase type I procollagen and decrease MMP1 expression in human epidermis (Rittie et al., 2008) . Here, we demonstrate that ERβ ligands could interfere with various steps involved in the etiology of photoaging. We show that ERβ ligands inhibit the expression of proinflamatory cytokines, and metalloproteinases in cell-based models of UVB-activated normal human epidermal keratinocytes (NHEKs) and cytokine-activated normal human dermal fibroblasts (NHDFs). We also demonstrate the efficacy of a synthetic ERβ ligand in a murine model MOL #62877 6 of UV-induced photoaging. Our observations indicate that ERβ is a potential novel target for photoaging, and could provide a new category of therapeutic agents for the prevention and treatment of this indication.
MATERIALS AND METHODS
ERβ selective compounds and other chemical reagents
Test compounds used in this study were supplied by the Wyeth compound library (Princeton, NJ) that were either purchased or synthesized by Wyeth Medicinal Chemistry (Collegeville, PA). All other chemicals and reagents obtained from various vendors and used in this study were reagent grade or better.
Skin cells and cell culture conditions
NHEKs and NHDFs (Cambrex/Lanza, Walkersville, MD), and human dermal fibroblasts cell lines, HFF and BJ-5ta (ATCC), as well as human epidermal keratinocyte cell line KERTr (ATCC) were cultured as per vendors' recommendations. In general, cells were trypsinized and seeded on day 0, compound treatments were done on day 1 with and without UVB (8 mJ/cm 2 , UV Stratalinker 2400, Stratagene, La Jolla, CA) or TNFα (1 ng/ml) activations, and cells were harvested on day 2 with lysis buffer (Applied Biosystems/Ambion, Foster City, CA) directly added to the cultured cells after a PBS wash. Cells were either used for RNA purification using Qiagen RNeasy RNA purification column (Qiagen, Hilden, Germany) as per vendor's protocol or directly processed to cDNA using "Cell-to-cDNA" lysis buffer (Ambion, Foster City, CA).
ERβ KO and heterozygote (HET) skin cell preparations
This article has not been copyedited and formatted. The final version may differ from this version. ERβ KO mice were generated at Wyeth Research as previously described (Shughrue et al., 2002) and are not the same as the β ERKO mice (Krege et al., 1998; Harris, 2007) . The epidermal and dermal layers were minced and subjected to several differential centrifugations, fractionations and filtrations as previously described (Zheng et al., 2005) .
These cells were then cultured in Eagle's minimal essential medium containing fetal bovine serum (8 %) in 24-well culture plates (day 0). Cells were treated with vehicle or ERβ-selective compounds on day 2, followed by isolation and purification of RNA on day 3 using RNeasy column (Qiagen, Hilden, Germany). Gene expression profiles were analyzed using Taqman Low Density Array (TLDA) and individual Taqman gene assays (Applied Biosystems, Foster City, CA). 
Murine model of photoaging
Five-week-old female albino hairless mice (Hos:HR-1) were obtained from the HOSHINO Laboratory Animals (HOS : Kotoh-cho, Japan). Animals had free access to food and water and were acclimated for 1 week before the study. Eight mice are allocated to each group (total six groups for each test compound). All experimental protocols were UV lamps (Philips, Eindhoven, Netherlands) with an emission spectrum between 275 and 380 nm (peak, 310-315 nm) served as the UV source (Seo et al., 2001) . A Kodacel filter (TA401/407; Kodak, Rochester, NY) was mounted 2 cm in front of the UV lamp to remove wavelengths of less than 290nm (UVC). Irradiation intensity at the mouse skin surface was measured using a UV meter (model 585100; Waldmann Co., Germany). The irradiation intensity 20 cm from the light source was 0.5 mW/cm 2 .
Initially, we measured the minimal erythma dose (MED) on dorsal skin of mice. MED can be defined as the minimum amount of radiation exposure required to produce an erythma with sharp margins after 48h. Mice were exposed to UV light 3 times per week (Monday, Wednesday and Friday) for 6 weeks. The irradiation dose was increased weekly by 1 MED (1MED = 100 mJ/cm 2 ) up to 4 MED and then maintained at 4 MED.
UV irradiation was stopped after irradiation for the sixth week. ERB-041 or its vehicle (70% ethanol, 30% polyethylene glycol) was topically applied to the dorsal area (50 μ l)
after each exposure to UV irradiation (5 times a week). Skin wrinkle replica was made with a silicon rubber (Silflo Dental Impression Material, Flexico developments, England) from the backs of unstrained mice. Skin impressions were photographed using a coupling charge system (CCD) video camera and analyzed by Skin-Visiometer SV 600 software (CK electronic GmbH, Germany).
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RESULTS
Identification of ERβ as a target for photoaging
In order to evaluate ERβ as a target for photoaging, normal human epidermal keratinocytes (NHEKs) were treated either with vehicle or a synthetic ERβ-selective ligand, WAY-200070 (Harris, 2007) In addition, it showed EC 50 (concentration of the ligand required for 50% increase in luciferase activity) values of 314 and 31 nM, respectively in Gal4-ERα-LBD and Gal4
ERβ-LBD transactivation assays (Table 1 ) (Malamas et al., 2004; Harris, 2007) . UV exposure induced the expression of MMPs, cytokines and COX-2 in NHEKs, and inhibited the expression of tissue inhibitor of metalloproteinases 1 (TIMP1) and collagen 1A1 (COL1A1) ( (Fig. 2E) . The difference in the degree of suppression between NHEK and NHDF cells may be because the method of cytokine induction differed (UV vs. TNFα ) between the two cell types.
Validation of ERβ as a target for photoaging
Since WAY-200070 is selective but not specific for ERβ, we next examined whether its potential anti-photoaging in vitro effects were specifically mediated via ERβ. To test mice (Shughrue et al., 2002; Ohnemus et al., 2005; Antal et al., 2008; Zhao et al., 2008) .
WAY-200070 inhibited the expression of Mmp13 (murine counterpart of human MMP1), and another ER-responsive gene, mitogen-activated protein kinase 1 (Mapk1) in ERβ heterozygote but not in KO keratinocytes (Fig. 3D, 3E ). (Malamas et al., 2004; Harris, 2007) . Therefore, ERB-041 is has shown efficacy in murine models of inflammation, we decided to use ERB-041 in a murine model of photoaging.
ERβ ligand inhibits wrinkle formation in vivo
We next examined whether the anti-inflammatory/anti-catabolic molecular changes observed with an ERβ compound in vitro translate into efficacy in a murine model of photoaging. Therefore, the effect of ERB-041 was examined on UV-induced wrinkle formation in a hairless albino mouse model (Chang et al., 2008) . The experimental plan included two groups of mice. One group was mock exposed [UV(-) group] and the second group of mice was exposed 3 times/week to UV treatment [UV(+) group]. The UV(-) group was further divided into two subgroups, wherein animals were treated topically with either vehicle or ERB-041 (10 mM) 5 times/week for 6 weeks. Similarly, the UV(+) group was divided into 4 subgroups, wherein mice were treated topically with vehicle or 0.1, 1.0 or 10 mM ERB-041 (Fig. 5A ). UV exposure of hairless mice for 6 weeks resulted in the appearance of prominent wrinkles in the UV(+) vehicle-treated group in comparison to mock-exposed groups, as shown by silicon rubber replicas of the mouse dorsal skin (Fig. 5A) . Replica scans showed a quantitative increase in wrinkle score in the UV(+), vehicle-treated group relative to UV(-), mock-exposed group (Fig.   5B ). Remarkably, a statistically significant decrease in wrinkle score was observed at all three doses of the ERβ ligand as compared to UV(+), vehicle-treated animals ( Figs. 5A and B). At 0.1 and 1 mM concentrations of ERB-041, wrinkle scores in the UV(+) groups
were not significantly different (P<0.05) from those of the UV(-) groups (Fig. 5B) . With 10 mM of ERB-041, wrinkling was reduced to a lesser extent; this high dose may have This article has not been copyedited and formatted. The final version may differ from this version. 
DISCUSSION
An explosion in the population of aged individuals has resulted in an increase in demand for products that can diminish wrinkles and maintain the youthful appearance of the skin. Currently, natural (retinoic acid, RA) and synthetic (tazarotene, Avage)
retinoids are the only class of topical prescription agents that are approved by Food and Drug Administration (FDA) for the treatment of photoaged skin (Goldfarb et al., 1990 ).
However, retinoid usage is associated with local skin side effects of irritation, erythema, burning, pruritus and scaling (McGuire et al., 1988; Effendy et al., 1996) . Other treatments, like botulinum toxins and hyaluronic acid fillers are injectable and painful, and they do not modulate the underlying etiological process of photoaging. Therefore, there is a need for safe and efficacious agents for the prevention and treatment of photoaging.
This manuscript provides the first evidence demonstrating ERβ as a novel target for the prevention and potentially the treatment of photoaging. In this study we demonstrate that ERβ-selective ligands exhibit molecular signatures of a potential photoaging therapeutic, since a synthetic specific agonist inhibited the expression of proinflammatory cytokines, MMPs and COX-2 in activated skin cells (Fig. 2) . The broad anti-inflammatory potential of an ERβ-selective compound did translate into efficacy in vivo, since it inhibited UV-induced wrinkle formation in a murine model of photoaging (Fig. 5 ).
Natural and synthetic estrogens have long been recognized for their ability to rejuvenate human skin. These estrogens were included in many skin care products, however no clear mechanisms of action were defined. A recent study showed that This article has not been copyedited and formatted. The final version may differ from this version. estrogen cream failed to protect sun damaged skin in a clinic (Rittie et al., 2008) . In this study, no significant changes in collagen production were observed in women or men after estradiol treatment of photoaged forearm or face skin. This is consistent with our unpublished results using estradiol in our in vitro photoaging model, wherein we found MMPs may lead to a reduction in collagen degradation and eventually the prevention of wrinkle formation. Furthermore, the inability of estradiol to suppress MMP1 in our in vitro photoaging model may explain why it did not improve sun-exposed human skin in the cited study (Rittie et al., 2008) . The data presented in this manuscript point to ERβ
and not ERα as the receptor responsible for mediating the anti-photoaging effect.
As ERβ ligands suppress several cytokines and MMP1, their anti-inflammatory effect is likely to involve NFκB pathways. Since retinoic acid, an FDA approved antiphotoaging retinoid, mainly suppresses AP1-responsive metalloproteinases, collagenase, stromelysin-1 and 92 Kd gelatinase (Fisher et al., 1996) and not NFκB-responsive cytokines (unpublished observations), retinoids may exert their anti-photoaging effects via inhibition of AP1-dependent gene expression (Herrlich and Ponta, 1994; Boehm et al., 1995) . Therefore, if successfully developed and approved, ERβ ligands will become a novel class of anti-photoaging agent. It has been postulated that This article has not been copyedited and formatted. The final version may differ from this version. the anti-inflammation potential of ERα/ERβ is tissue/cell type specific (Brandenberger et al., 1997) . ERα plays a more important role in the uterus, whereas ERβ appears to play important roles in ovary, cardiovascular system and brain (Brandenberger et al., 1997) .
Although much evidence points to the clear involvement of an NF-κB mediated mechanism for the anti-inflammatory activities of ERs, most of this evidence also suggests the involvement of other co-factors (Guzeloglu-Kayisli et al., 2008) . For example, ER ligands have been proposed to mediate their anti-inflammatory effects by inhibiting NF-kB-dependent gene expression via involvement of cofactor SRC-2 (Cvoro et al., 2006; Cvoro et al., 2008) . Binding of our ERβ ligands may allow more effective interaction of ERβ with SRC-2, thus providing more potent ERβ-mediated antiinflammatory activity than estradiol. Based on our findings, we conclude that ERβ, but not ERα, plays a major role in reversing the process of photoaging in skin, and its antiphotoaging activity could potentially involve cofactor recruitment or NF-κB mediated mechanism or both.
Our recent publication showed that treatment with an LXR ligand significantly prevented UV-induced skin thickening as well as reducing skin wrinkling (Chang et al., 2008 ). In the current study, although the ERβ ligand was more efficacious than an LXR combination of these two nuclear receptor ligands might be most efficacious for preventing and treating photoaging.
In summary, we have identified ERβ as a target for photoaging, and shown that selective ligands could reverse the in vitro photoaging process at least at the molecular level. A proof of concept study using ERΒ-041 showed statistically significant reversal of wrinkle formation in a murine photoaging model ( This article has not been copyedited and formatted. The final version may differ from this version. and 10 mM) of ERB-041 after 6 weeks of topical treatment is shown. The mice were either mock irradiated [UV (-)] or exposed to UV radiation [UV (+)] three times a week.
The UV dose was increased weekly by 1MED (1MED = 130 mJ/cm2) to a maximum of 4MED and subsequently maintained at this level for the remainder of the study period.
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